Cargando…
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation
Pathological cardiac hypertrophy eventually leads to heart failure without adequate treatment. The immunoproteasome is an inducible form of the proteasome that is intimately involved in inflammatory diseases. Here, we found that the expression and activity of immunoproteasome catalytic subunit β5i w...
Autores principales: | Xie, Xin, Bi, Hai-Lian, Lai, Song, Zhang, Yun-Long, Li, Nan, Cao, Hua-Jun, Han, Ling, Wang, Hong-Xia, Li, Hui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506244/ https://www.ncbi.nlm.nih.gov/pubmed/31086810 http://dx.doi.org/10.1126/sciadv.aau0495 |
Ejemplares similares
-
Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy
por: Xie, Xin, et al.
Publicado: (2020) -
Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
por: Chen, Chen, et al.
Publicado: (2018) -
Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis
por: Hewing, Bernd, et al.
Publicado: (2017) -
MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4B
por: Zhang, Yuhong, et al.
Publicado: (2022) -
The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice
por: Wang, Shuai, et al.
Publicado: (2018)